{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein (a-Syn) has attracted considerable attention due to its involvement in Parkinson's disease (PD), which is characterized by the selective and progressive loss of dopaminergic neurons in substantia nigra pars compacta.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, which is the involvement of a-Syn in PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "To evaluate effects of a-Syn overexpression against environmental toxin insults, SH-SY5Y cell lines were exposed to acute rotenone or maneb treatment.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (cell viability assay following toxin exposure) effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "MTT results showed that rotenone and maneb markedly induced SH-SY5Y cell death in a concentration-dependent manner.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of controls and replicates, indicating a valid assay setup.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "a-Syn mutants (A30P, A53T and E46K) showed significantly lower cell viability following 0.50 mM and 1.00 mM rotenone treatment (p < 0.05).",
          "judgment": "Yes",
          "reasoning": "The statistical analyses support the pathogenic effect of the A30P variant.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "The mutants exacerbate rotenone-and maneb-induced ROS production and subsequent neurotoxicity.",
          "judgment": "Yes",
          "reasoning": "The data suggests a strong pathogenic effect, supporting a high OddsPath.",
          "next_step_or_outcome": "Assign PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The A30P variant in SNCA exacerbates toxin-induced neurotoxicity and ROS production, supporting a very strong pathogenic functional evidence."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein (a-Syn) has attracted considerable attention due to its involvement in Parkinson's disease (PD), which is characterized by the selective and progressive loss of dopaminergic neurons in substantia nigra pars compacta.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, which is the involvement of a-Syn in PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "To evaluate effects of a-Syn overexpression against environmental toxin insults, SH-SY5Y cell lines were exposed to acute rotenone or maneb treatment.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (cell viability assay following toxin exposure) effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "MTT results showed that rotenone and maneb markedly induced SH-SY5Y cell death in a concentration-dependent manner.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of controls and replicates, indicating a valid assay setup.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "a-Syn mutants (A30P, A53T and E46K) showed significantly lower cell viability following 0.50 mM and 1.00 mM rotenone treatment (p < 0.05).",
          "judgment": "Yes",
          "reasoning": "The statistical analyses support the pathogenic effect of the A53T variant.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "The mutants exacerbate rotenone-and maneb-induced ROS production and subsequent neurotoxicity.",
          "judgment": "Yes",
          "reasoning": "The data suggests a strong pathogenic effect, supporting a high OddsPath.",
          "next_step_or_outcome": "Assign PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The A53T variant in SNCA exacerbates toxin-induced neurotoxicity and ROS production, supporting a very strong pathogenic functional evidence."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein (a-Syn) has attracted considerable attention due to its involvement in Parkinson's disease (PD), which is characterized by the selective and progressive loss of dopaminergic neurons in substantia nigra pars compacta.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, which is the involvement of a-Syn in PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "To evaluate effects of a-Syn overexpression against environmental toxin insults, SH-SY5Y cell lines were exposed to acute rotenone or maneb treatment.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (cell viability assay following toxin exposure) effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "MTT results showed that rotenone and maneb markedly induced SH-SY5Y cell death in a concentration-dependent manner.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of controls and replicates, indicating a valid assay setup.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "a-Syn mutants (A30P, A53T and E46K) showed significantly lower cell viability following 0.50 mM and 1.00 mM rotenone treatment (p < 0.05).",
          "judgment": "Yes",
          "reasoning": "The statistical analyses support the pathogenic effect of the E46K variant.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "The mutants exacerbate rotenone-and maneb-induced ROS production and subsequent neurotoxicity.",
          "judgment": "Yes",
          "reasoning": "The data suggests a strong pathogenic effect, supporting a high OddsPath.",
          "next_step_or_outcome": "Assign PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The E46K variant in SNCA exacerbates toxin-induced neurotoxicity and ROS production, supporting a very strong pathogenic functional evidence."
    }
  ]
}